DBVTF
DBV TECHNOLOGIES
Price Chart
Latest Quote
$4.26
+0.00 (+0.00%)
Current Price
| Previous Close | $4.26 |
| Open | $4.30 |
| Day High | $4.30 |
| Day Low | $4.30 |
| Volume | 100 |
Stock Information
| Shares Outstanding | 295.93M |
| Total Debt | $6.10M |
| Cash Equivalents | $229.20M |
| Revenue | $5.74M |
| Net Income | $-167.45M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $1.26B |
| EPS (TTM) | $-0.90 |
| Exchange | PNK |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $1.04B |
| Sales | $5.74M |
| Income | $-167.45M |
| Book/sh | $0.70 |
| Cash/sh | $0.77 |
| Employees | 161 |
Financial Ratios
| Quick Ratio | 4.72 |
| Current Ratio | 4.76 |
| Debt/Eq | 2.93 |
Returns & Margins
| ROA | -66.36% |
| ROE | -158.89% |
| Gross Margin | 100.00% |
| Operating Margin | -5311.11% |
Ownership
| Insider Ownership | 0.13% |
| Institutional Ownership | 51.39% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| P/S | 219.78 |
| P/B | 6.06 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $4.26 |
| SMA50 | $4.27 |
| SMA200 | $2.22 |
| RSI | nan |
| Shares Float | 176.27M |
| Volatility | -0.22 |
Performance History
| Week | +0.00% |
| Month | +0.00% |
| Quarter | -0.93% |
| 6 Months | +4259900.34% |
| YTD | +4259900.34% |
| Year | +442.07% |
| 3 Years | +2.40% |
| 5 Years | -77.59% |
| 10 Years | -93.51% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $4.26 | 0 |
| 2026-06-17 | $4.26 | 0 |
| 2026-06-16 | $4.26 | 0 |
| 2026-06-15 | $4.26 | 0 |
| 2026-06-12 | $4.26 | 0 |
| 2026-06-11 | $4.26 | 0 |
| 2026-06-10 | $4.26 | 0 |
| 2026-06-09 | $4.26 | 0 |
| 2026-06-08 | $4.26 | 0 |
| 2026-06-05 | $4.26 | 0 |
| 2026-06-04 | $4.26 | 0 |
| 2026-06-03 | $4.26 | 0 |
| 2026-06-02 | $4.26 | 0 |
| 2026-06-01 | $4.26 | 0 |
| 2026-05-29 | $4.26 | 0 |
| 2026-05-28 | $4.26 | 0 |
| 2026-05-27 | $4.26 | 0 |
| 2026-05-26 | $4.26 | 0 |
| 2026-05-22 | $4.26 | 0 |
| 2026-05-21 | $4.26 | 0 |
| 2026-05-20 | $4.26 | 0 |
| 2026-05-19 | $4.26 | 0 |
About DBV TECHNOLOGIES
DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products in France. Its product pipeline comprising Viaskin Peanut, an immunotherapy product, which has completed Phase 3 clinical trial for the treatment of peanut allergies; and Viaskin Milk which is in Phase 1/2 clinical trial for the treatment of immunoglobulin E (IgE) mediated or cow's milk protein allergy and eosinophilic esophagitis. The company's earlier stage research programs include celiac disease. In addition, the company develops Viaskin technology platform, a platform to potentially treat food allergy. It has a collaboration with NestlÊ Health Science to develop MAG1C, a ready-to-use atopy patch test for the diagnosis of non-IgE mediated CMPA in infants and toddlers. DBV Technologies S.A. was incorporated in 2002 and is headquartered in ChÃĸtillon, France.
đ° Latest News
DBV Technologies (ENXTPA:DBV) Advances Peanut Patch With New Phase 3 Data And Infant Trial
Simply Wall St. âĸ 2026-06-17T20:15:40Z
European Equities Traded in the US as American Depositary Receipts Slightly Higher in Tuesday Trading
MT Newswires âĸ 2026-06-16T15:08:44ZEuropean Equities Traded in the US as American Depositary Receipts Increase in Friday Trading; Rise for Week
MT Newswires âĸ 2026-06-12T15:14:33ZEuropean Equities Traded in the US as American Depositary Receipts Decline in Friday Trading; Rise for Week
MT Newswires âĸ 2026-06-05T15:06:40ZEuropean Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading
MT Newswires âĸ 2026-06-04T15:08:32ZEuropean Equities Traded in the US as American Depositary Receipts Little Changed in Thursday Trading
MT Newswires âĸ 2026-05-21T15:05:36ZEuropean Equities Traded in the US as American Depositary Receipts Open Week Tracking Higher in Monday Trading
MT Newswires âĸ 2026-05-18T15:11:28ZEuropean Equities Traded in the US as American Depositary Receipts Flat in Wednesday Trading
MT Newswires âĸ 2026-05-13T15:12:40ZEuropean Equities Traded in the US as American Depositary Receipts Decline Sharply in Tuesday Trading
MT Newswires âĸ 2026-05-12T15:14:29ZEuropean Equities Traded in the US as American Depositary Receipts Start Week on Flat Note in Monday Trading
MT Newswires âĸ 2026-05-11T15:05:40Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Total Revenue | $0 | $0 | $0 | $0 |
| Operating Revenue | $0 | $0 | $0 | $0 |
| Expenses | ||||
| Total Expenses | $116,590,000 | $76,433,000 | $96,631,000 | $99,535,000 |
| Net Non Operating Interest Income Expense | $2,726,000 | $3,714,000 | $427,000 | $425,000 |
| Total Other Finance Cost | $-2,726,000 | $-3,714,000 | $-427,000 | $-425,000 |
| Operating Expense | $116,590,000 | $76,433,000 | $96,631,000 | $99,535,000 |
| Other Operating Expenses | $-5,000 | $-6,962,000 | $874,000 | $1,797,000 |
| General And Administrative Expense | $23,854,000 | $22,777,000 | $17,563,000 | $21,688,000 |
| Other Income Expense | - | - | - | $920,000 |
| Selling And Marketing Expense | - | - | - | $4,387,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-113,918,000 | $-72,726,000 | $-96,274,000 | $-97,809,000 |
| Net Interest Income | $2,726,000 | $3,714,000 | $427,000 | $425,000 |
| Normalized Income | $-113,918,000 | $-72,726,000 | $-96,274,000 | $-98,725,412 |
| Net Income From Continuing And Discontinued Operation | $-113,918,000 | $-72,726,000 | $-96,274,000 | $-97,809,000 |
| Total Operating Income As Reported | $-116,589,000 | $-76,432,000 | $-96,631,000 | $-98,614,000 |
| Net Income Common Stockholders | $-113,918,000 | $-72,726,000 | $-96,274,000 | $-97,809,000 |
| Net Income | $-113,918,000 | $-72,726,000 | $-96,274,000 | $-97,809,000 |
| Net Income Including Noncontrolling Interests | $-113,918,000 | $-72,726,000 | $-96,274,000 | $-97,809,000 |
| Net Income Continuous Operations | $-113,918,000 | $-72,726,000 | $-96,274,000 | $-97,809,000 |
| Pretax Income | $-113,863,000 | $-72,719,000 | $-96,204,000 | $-98,189,000 |
| Operating Income | $-116,590,000 | $-76,433,000 | $-96,631,000 | $-99,535,000 |
| Depreciation Amortization Depletion Income Statement | $7,545,000 | $9,161,000 | $8,369,000 | $13,219,000 |
| Depreciation And Amortization In Income Statement | $7,545,000 | $9,161,000 | $8,369,000 | $13,219,000 |
| Special Income Charges | - | - | $0 | $920,000 |
| Per Share | ||||
| Diluted EPS | $-1.17 | $-0.76 | $-1.24 | $-1.78 |
| Basic EPS | $-1.17 | $-0.76 | $-1.24 | $-1.78 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $3,588 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-109,045,000 | $-67,272,000 | $-83,469,000 | $-87,236,000 |
| Reconciled Depreciation | $-925,000 | $-13,998,000 | $13,162,000 | $8,376,000 |
| EBITDA (Bullshit earnings) | $-109,045,000 | $-67,272,000 | $-83,469,000 | $-86,316,000 |
| EBIT | $-116,590,000 | $-76,433,000 | $-96,631,000 | $-99,535,000 |
| Diluted Average Shares | $97,350,427 | $95,121,390 | $77,661,290 | $54,948,876 |
| Basic Average Shares | $97,350,427 | $95,121,390 | $77,661,290 | $54,948,876 |
| Diluted NI Availto Com Stockholders | $-113,918,000 | $-72,726,000 | $-96,274,000 | $-97,809,000 |
| Tax Provision | $55,000 | $7,000 | $70,000 | $-381,000 |
| Other Taxes | $-4,146,000 | $-8,766,000 | $-5,718,000 | $-7,505,000 |
| Research And Development | $89,342,000 | $60,223,000 | $75,543,000 | $70,336,000 |
| Selling General And Administration | $23,854,000 | $22,777,000 | $17,563,000 | $21,688,000 |
| Other Gand A | $11,822,000 | $10,434,000 | $6,641,000 | $10,446,000 |
| Salaries And Wages | $12,032,000 | $12,343,000 | $10,922,000 | $11,242,000 |
| Total Unusual Items | - | - | $0 | $920,000 |
| Total Unusual Items Excluding Goodwill | - | - | $0 | $920,000 |
| Restructuring And Mergern Acquisition | - | - | $0 | $-920,000 |
Fetched: 2026-02-02
Balance Sheet (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $27,348,000 | $140,128,000 | $194,444,000 | $99,253,000 |
| Total Assets | $65,658,000 | $182,986,000 | $246,518,000 | $146,723,000 |
| Total Non Current Assets | $21,271,000 | $24,071,000 | $23,444,000 | $32,338,000 |
| Non Current Accounts Receivable | $111,000 | - | $312,000 | $199,000 |
| Investmentin Financial Assets | $4,312,000 | - | $1,773,000 | $2,665,000 |
| Goodwill And Other Intangible Assets | $40,000 | $58,000 | $10,000 | $22,000 |
| Current Assets | $44,388,000 | $158,915,000 | $223,074,000 | $114,386,000 |
| Prepaid Assets | $1,541,000 | $2,103,000 | $2,680,000 | $4,149,000 |
| Receivables | $10,391,000 | $15,446,000 | $11,199,000 | $32,935,000 |
| Other Receivables | $1,959,000 | $1,353,000 | $1,504,000 | $1,282,000 |
| Taxes Receivable | $8,432,000 | $14,093,000 | $9,695,000 | $31,653,000 |
| Cash Cash Equivalents And Short Term Investments | $32,456,000 | $141,367,000 | $209,194,000 | $77,301,000 |
| Cash And Cash Equivalents | $32,456,000 | $141,367,000 | $209,194,000 | $77,301,000 |
| Cash Equivalents | $0 | $130,836,000 | $179,090,000 | $45,874,000 |
| Cash Financial | $32,456,000 | $10,530,000 | $30,104,000 | $31,427,000 |
| Other Non Current Assets | - | $6,085,000 | $3,740,000 | $3,970,000 |
| Other Current Assets | - | $-1,000 | $1,000 | $1,000 |
| Accounts Receivable | - | $0 | $0 | $0 |
| Non Current Prepaid Assets | - | - | $1,773,000 | $2,665,000 |
| Debt | ||||
| Total Debt | $7,797,000 | $6,553,000 | $4,152,000 | $11,985,000 |
| Long Term Debt And Capital Lease Obligation | $6,297,000 | $4,526,000 | $1,127,000 | $7,147,000 |
| Current Debt And Capital Lease Obligation | $1,500,000 | $2,027,000 | $3,025,000 | $4,838,000 |
| Current Debt | $846,000 | $883,000 | $1,131,000 | $1,835,000 |
| Other Current Borrowings | $846,000 | $883,000 | $1,131,000 | $1,835,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $38,271,000 | $42,799,000 | $52,065,000 | $47,449,000 |
| Total Non Current Liabilities Net Minority Interest | $7,135,000 | $5,460,000 | $22,544,000 | $16,052,000 |
| Other Non Current Liabilities | $838,000 | $934,000 | $21,417,000 | $8,905,000 |
| Current Liabilities | $31,136,000 | $37,339,000 | $29,521,000 | $31,397,000 |
| Other Current Liabilities | $7,416,000 | $11,787,000 | $9,817,000 | $10,802,000 |
| Payables And Accrued Expenses | $22,220,000 | $23,525,000 | $14,542,000 | $11,611,000 |
| Payables | $22,220,000 | $23,525,000 | $14,542,000 | $11,611,000 |
| Total Tax Payable | $188,000 | $223,000 | $69,000 | $182,000 |
| Accounts Payable | $22,032,000 | $23,302,000 | $14,473,000 | $11,429,000 |
| Current Deferred Liabilities | - | $0 | $2,137,000 | $4,146,000 |
| Equity | ||||
| Common Stock Equity | $27,388,000 | $140,186,000 | $194,454,000 | $99,275,000 |
| Total Equity Gross Minority Interest | $27,387,000 | $140,187,000 | $194,453,000 | $99,274,000 |
| Stockholders Equity | $27,388,000 | $140,186,000 | $194,454,000 | $99,275,000 |
| Gains Losses Not Affecting Retained Earnings | $-12,192,000 | $-8,129,000 | $-13,800,000 | $-5,618,000 |
| Other Equity Adjustments | $905,000 | $742,000 | $781,000 | $519,000 |
| Retained Earnings | $-286,375,000 | $-238,862,000 | $-259,578,000 | $-258,528,000 |
| Other | ||||
| Treasury Shares Number | $266,868 | $222,988 | $149,793 | $153,631 |
| Ordinary Shares Number | $102,580,633 | $96,208,782 | $93,987,352 | $54,942,131 |
| Share Issued | $102,847,501 | $96,431,770 | $94,137,145 | $55,095,762 |
| Tangible Book Value | $27,348,000 | $140,128,000 | $194,444,000 | $99,253,000 |
| Invested Capital | $28,234,000 | $141,069,000 | $195,585,000 | $101,110,000 |
| Working Capital | $13,252,000 | $121,576,000 | $193,553,000 | $82,989,000 |
| Capital Lease Obligations | $6,951,000 | $5,670,000 | $3,021,000 | $10,150,000 |
| Total Capitalization | $27,388,000 | $140,186,000 | $194,454,000 | $99,275,000 |
| Foreign Currency Translation Adjustments | $-13,097,000 | $-8,871,000 | $-14,581,000 | $-6,137,000 |
| Treasury Stock | $1,309,000 | $1,263,000 | $1,109,000 | $1,232,000 |
| Additional Paid In Capital | $315,613,000 | $377,468,000 | $458,221,000 | $358,115,000 |
| Capital Stock | $11,651,000 | $10,972,000 | $10,720,000 | $6,538,000 |
| Common Stock | $11,651,000 | $10,972,000 | $10,720,000 | $6,538,000 |
| Long Term Capital Lease Obligation | $6,297,000 | $4,526,000 | $1,127,000 | $7,147,000 |
| Current Capital Lease Obligation | $654,000 | $1,144,000 | $1,894,000 | $3,003,000 |
| Investments And Advances | $4,312,000 | - | $1,773,000 | $2,665,000 |
| Available For Sale Securities | $4,312,000 | - | $1,773,000 | $2,665,000 |
| Net PPE | $16,808,000 | $17,928,000 | $17,609,000 | $25,482,000 |
| Accumulated Depreciation | $-17,528,000 | $-18,954,000 | $-14,788,000 | $-13,799,000 |
| Gross PPE | $34,336,000 | $36,882,000 | $32,397,000 | $39,281,000 |
| Construction In Progress | $1,185,000 | $1,462,000 | $4,468,000 | $4,390,000 |
| Other Properties | $30,050,000 | $30,890,000 | $22,972,000 | $28,770,000 |
| Machinery Furniture Equipment | $3,101,000 | $4,530,000 | $1,743,000 | $2,163,000 |
| Current Deferred Revenue | - | $0 | $2,137,000 | $4,146,000 |
| Buildings And Improvements | - | $3,327,000 | $3,214,000 | $3,958,000 |
| Properties | - | $0 | $0 | $0 |
Fetched: 2026-02-02
Cash Flow Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-106,815,000 | $-80,330,000 | $-56,420,000 | $-109,160,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-104,474,000 | $-79,653,000 | $-55,666,000 | $-108,242,000 |
| Cash Flow From Continuing Operating Activities | $-104,474,000 | $-79,653,000 | $-55,668,000 | $-108,242,000 |
| Operating Gains Losses | - | $76,000 | $105,000 | $184,000 |
| Investing Activities | ||||
| Capital Expenditure | $-2,341,000 | $-677,000 | $-754,000 | $-918,000 |
| Investing Cash Flow | $-757,000 | $-808,000 | $-100,000 | $-433,000 |
| Cash Flow From Continuing Investing Activities | $-757,000 | $-808,000 | $-99,000 | $-433,000 |
| Net Other Investing Changes | $1,584,000 | $-131,000 | $-1,000 | - |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $-47,000 | $-154,000 | - | - |
| Issuance Of Capital Stock | $634,000 | $6,921,000 | $194,594,000 | $978,000 |
| Financing Cash Flow | $587,000 | $6,767,000 | $194,120,000 | $274,000 |
| Cash Flow From Continuing Financing Activities | $587,000 | $6,767,000 | $194,120,000 | $274,000 |
| Net Common Stock Issuance | $587,000 | $6,767,000 | $194,594,000 | $978,000 |
| Common Stock Issuance | $634,000 | $6,921,000 | $194,594,000 | $978,000 |
| Net Other Financing Charges | - | - | $-474,000 | $-704,000 |
| Other | ||||
| End Cash Position | $32,456,000 | $141,367,000 | $209,194,000 | $77,301,000 |
| Beginning Cash Position | $141,367,000 | $209,194,000 | $77,301,000 | $196,352,000 |
| Effect Of Exchange Rate Changes | $-4,268,000 | $5,867,000 | $-6,461,000 | $-10,651,000 |
| Changes In Cash | $-104,643,000 | $-73,694,000 | $138,354,000 | $-108,400,000 |
| Common Stock Payments | $-47,000 | $-154,000 | - | - |
| Net Intangibles Purchase And Sale | $-3,000 | $0 | $0 | $-8,000 |
| Purchase Of Intangibles | $-3,000 | $0 | $0 | $-8,000 |
| Net PPE Purchase And Sale | $-2,338,000 | $-677,000 | $-746,000 | $-306,000 |
| Purchase Of PPE | $-2,338,000 | $-677,000 | $-754,000 | $-910,000 |
| Change In Working Capital | $5,752,000 | $953,000 | $22,320,000 | $-22,771,000 |
| Change In Other Working Capital | $485,000 | $1,662,000 | $-2,249,000 | $-1,185,000 |
| Change In Other Current Liabilities | $366,000 | $-5,334,000 | $152,000 | $-7,599,000 |
| Change In Other Current Assets | $4,629,000 | $-3,795,000 | $20,961,000 | $-8,578,000 |
| Change In Payables And Accrued Expense | $272,000 | $8,420,000 | $3,456,000 | $-7,559,000 |
| Change In Payable | $272,000 | $8,420,000 | $3,456,000 | $-7,559,000 |
| Change In Account Payable | $272,000 | $8,420,000 | $3,456,000 | $-7,559,000 |
| Other Non Cash Items | $-3,000 | $23,000 | $-5,000 | $656,000 |
| Stock Based Compensation | $4,620,000 | $6,019,000 | $5,026,000 | $3,122,000 |
| Depreciation Amortization Depletion | $-925,000 | $-13,998,000 | $13,162,000 | $8,376,000 |
| Depreciation And Amortization | $-925,000 | $-13,998,000 | $13,162,000 | $8,376,000 |
| Depreciation | $-925,000 | $-13,998,000 | $13,162,000 | $8,376,000 |
| Pension And Employee Benefit Expense | $0 | $76,000 | $105,000 | $184,000 |
| Net Income From Continuing Operations | $-113,918,000 | $-72,726,000 | $-96,274,000 | $-97,809,000 |
| Net Investment Purchase And Sale | - | $-131,000 | $647,000 | $-119,000 |
| Sale Of Investment | - | $154,000 | $770,000 | $0 |
| Purchase Of Investment | - | $-285,000 | $-123,000 | $-119,000 |
| Sale Of PPE | - | $0 | $8,000 | $604,000 |
| Change In Inventory | - | $0 | $0 | $0 |
| Change In Receivables | - | $0 | $0 | $2,150,000 |
| Changes In Account Receivables | - | $0 | $0 | $2,150,000 |
Fetched: 2026-02-02